http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IT-MI982299-D0
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_89b60e340c7765626013119f28c35bfd |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K- |
filingDate | 1998-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_405ab5851ff71494b1eb9cd9bd706f18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6727c1581f78ef559672284e805654d0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db0d02e06abbd42dbc78de355d87eb9b |
publicationDate | 1998-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | IT-MI982299-D0 |
titleOfInvention | USE OF OTILONIUM BROMIDE AS AN NK2 ANTAGONIST AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT |
priorityDate | 1998-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Predicate | Subject |
---|---|
isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID72092 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453502507 |
Total number of triples: 13.